ℹ️
🇬🇧
Search
Search for publications relevant for "trastuzumab"
trastuzumab
Publication
Class
Person
Publication
Programmes
Export current view
publication
Retreatment with trastuzumab in HER-2 positive metastatic breast cancer progressing after trastuzumab and lapatinib
2012 |
First Faculty of Medicine
publication
Trastuzumab and heart damage
2012 |
First Faculty of Medicine
publication
Pharmacological profile – trastuzumab emtansine
2022 |
Third Faculty of Medicine
publication
Trastuzumab-induced cardiotoxicity: a review
2023 |
Third Faculty of Medicine
publication
Trastuzumab deruxtecan: strong player in the field of metastatic HER2 positive breast cancer
2022 |
First Faculty of Medicine
publication
Trastuzumab deruxtecan in the treatment of patients with metastatic HER2‑low breast cancer
2023 |
First Faculty of Medicine
publication
What next for the failure of treatment with trastuzumab in HER2-dependent metastatic breast cancer
2009 |
First Faculty of Medicine
publication
Is there a qualitative interaction between adjuvant trastuzumab and size of the primary tumor in breast cancer?
2008 |
First Faculty of Medicine
publication
Trastuzumab in breast cancer treatment algorithm
2010 |
First Faculty of Medicine
publication
Trastuzumab emtansine in the treatment of residual HER2-positive breast cancer
2019 |
First Faculty of Medicine
publication
Trastuzumab deruxtecan as standard of care for second-line treatment of metastatic HER2-positive breast cancer
2023 |
First Faculty of Medicine
publication
Use of Trastuzumab for Neoadjuvant Therapy of HER2+ Breast Cancer - 5-Years of Experience in a Single Clinic
2018 |
First Faculty of Medicine
publication
Effect of neoadjuvant Herceptin (trastuzumab) in a patient with breast cancer with high growth activity
2009 |
First Faculty of Medicine
publication
Subcutaneous vs. intravenous application of trastuzumab in neoadjuvant setting in breast cancer HER2+ patient stage I-III, HannaH trial
2012 |
First Faculty of Medicine
publication
Trastuzumab deruxtekan
2021 |
First Faculty of Medicine
publication
Biological treatment with trastuzumab in the neoadjuvant therapy of breast cancer
2009 |
First Faculty of Medicine
publication
Report of University Hospital Hradec Králové to the clinical trial protocol No: BO27938
Publication without faculty affiliation
publication
Is there a qualitative interaction between adjuvant trastuzumab and size of the primary tumor in breast cancer?
2008 |
Faculty of Medicine in Hradec Králové
publication
News in anti-HER2 targeted therapy in breast cancer
+1
2013 |
First Faculty of Medicine
publication
The current location of trastuzumab in the treatment of HER2 positive breast cancer
2009 |
First Faculty of Medicine
publication
Report of University Hospital Hradec Králové to the clinical trial protocol No: BO28407
Publication without faculty affiliation
publication
The advantage of Herceptin SC and advantage of the originator
2017 |
Faculty of Medicine in Pilsen
publication
Research Report University Hospital clinical trial BO28407
Publication without faculty affiliation
publication
Fixní kombinace pertuzumabu a trastuzumabu v subkutánní injekci
2021 |
First Faculty of Medicine
publication
Final report of University Hospital Hradec Kralove to the clinical trial protocol no. Final report of University Hospital Hradec Kralove to the clinical trial protocol no. BO28407
Publication without faculty affiliation
publication
Research Report University Hospital of the clinical trial BO27938
Publication without faculty affiliation
publication
First-line trastuzumab (H), oral vinorelbine (NVBo) and capecitabine (X) combination therapy for HER2-positive metastatic breast cancer (MBC): efficacy and safety in a multinational phase 2 study
Publication without faculty affiliation
publication
Lapatinib and the treatment of metastatic breast cancer treated by trastuzumab
2009 |
First Faculty of Medicine
publication
Management and outcome of HER2-positive early breast cancer treated with or without trastuzumab in the adjuvant trastuzumab era
2011 |
Third Faculty of Medicine